Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, recognizes this year's World Diabetes Day and National Diabetes...
The results of the PROTECT clinical trial shared today by Sanofi and presented at the International Society for Pediatric and Adolescent Diabetes...
JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, is thrilled to announce NFL Super Bowl Champion and Cincinnati...
Today, JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, urged members of the Senate Appropriations Committee to...
JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, is thrilled to announce the lineup for the 2023 JDRF Children's...
JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, joined thousands within the diabetes community at the American...
JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, is thrilled to announce the 2023 JDRF Children's Congress, a...
In recognition of Healthy Vision Month, JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, encourages everyone living ...
Today, JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, presented the inaugural Mary Tyler Moore Awards to three...
JDRF, the leading global funder of type 1 diabetes (T1D) research, is recognizing football stars showcasing their passion and creativity to bring...
JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, applauds today's decision from the U.S Food and Drug...
JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, recognizes this year's National Diabetes Awareness Month (NDAM) by ...
JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, together with the University of California, San Francisco (UCSF),...
JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, announces the launch of the Type 1 Diabetes Index (T1D Index). The ...
JDRF, la principal organización mundial de investigación y defensa de la diabetes tipo 1, anuncia el lanzamiento del Índice de la Diabetes Tipo 1...
JDRF, a principal organização global de pesquisa e defesa do diabetes tipo 1 (DM1), anuncia o lançamento do Índice de Diabetes Tipo 1 (T1DIndex). O...
La FRDJ, le principal organisme de recherche et de défense du diabète de type 1 (DT1), annonce le lancement de l'indice du diabète de type 1...
Die JDRF, die weltweit führende Forschungs- und Interessenvertretungsorganisation für Typ-1-Diabetes (T1D), gibt die Einführung des...
JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, proudly announces the support of the Defeat Diabetes team in the...
JDRF, the leading global type 1 diabetes (T1D) research and advocacy non-profit, joined NBA Miami Heat Assistant Coach and Racine, Wisconsin native...
JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, applauds the new proposed legislation announced by U.S. Senators...
JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, together with UMass Chan Medical School announces the appointment...
JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, announces the launch of the 2022 vehicle sweepstakes for JDRF....
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.